JXSL2101092 | Ziltivekimab 注射液 | ziltivekimab | Injection | Biological Products(1) | Import Drug Application | 2021-08-12 | | Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S | | | view |
JXSL2400010 | Ziltivekimab 注射液 | ziltivekimab | Injection | Biological Products(1) | Import Drug Application | 2024-01-10 | | Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S | | | view |
JXSB2500048 | Ziltivekimab 注射液 | ziltivekimab | Injection | Biological Products(1) | Supplementary Application | 2025-06-04 | | Vetter Pharma-Fertigung Gmbh & Co KG;Novo Nordisk A/S | | | view |
JXSB2300138 | Ziltivekimab 注射液 | ziltivekimab | Injection | Biological Products(1) | Supplementary Application | 2023-11-30 | | Vetter Pharma-Fertigung Gmbh & Co KG;Novo Nordisk A/S | | | view |
JXSB2500033 | Ziltivekimab 注射液 | ziltivekimab | Injection | Biological Products(1) | Supplementary Application | 2025-05-08 | | Vetter Pharma-Fertigung Gmbh & Co KG;Novo Nordisk A/S | | | view |
JXSB2300102 | Ziltivekimab 注射液 | ziltivekimab | Injection | Biological Products(1) | Supplementary Application | 2023-08-17 | | Vetter Pharma-Fertigung Gmbh & Co KG;Novo Nordisk A/S | | | view |
JXSB2400177 | Ziltivekimab 注射液 | ziltivekimab | Injection | Biological Products | Supplementary Application | 2024-12-26 | | Vetter Pharma-Fertigung Gmbh & Co KG;Novo Nordisk A/S | | | view |
JXSB2300034 | Ziltivekimab 注射液 | ziltivekimab | Injection | Biological Products(1) | Supplementary Application | 2023-03-31 | | Vetter Pharma-Fertigung Gmbh & Co KG;Novo Nordisk A/S | | | view |
JXSB2400066 | Ziltivekimab 注射液 | ziltivekimab | Injection | Biological Products | Supplementary Application | 2024-06-01 | | Vetter Pharma-Fertigung Gmbh & Co KG;Novo Nordisk A/S | | | view |
JXSL2300017 | Ziltivekimab 注射液 | ziltivekimab | Injection | Biological Products(1) | Import Drug Application | 2023-01-06 | | Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S | | | view |
JXSB2400065 | Ziltivekimab 注射液 | ziltivekimab | Injection | Biological Products(1) | Supplementary Application | 2024-05-30 | | Vetter Pharma-Fertigung Gmbh & Co KG;Novo Nordisk A/S | | | view |